Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 1 242.4 INR -3.73% Market Closed
Market Cap: 5.5B INR
Have any thoughts about
Jenburkt Pharmaceuticals Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Jenburkt Pharmaceuticals Ltd

Current Assets 1B
Cash & Short-Term Investments 780.9m
Receivables 153.7m
Other Current Assets 107.4m
Non-Current Assets 772.8m
Long-Term Investments 319.6m
PP&E 146.8m
Intangibles 2.9m
Other Non-Current Assets 303.5m
Current Liabilities 177m
Accounts Payable 57.2m
Accrued Liabilities 13.6m
Short-Term Debt 4.1m
Other Current Liabilities 102.2m
Non-Current Liabilities 60.1m
Long-Term Debt 17.1m
Other Non-Current Liabilities 43m

Balance Sheet
Jenburkt Pharmaceuticals Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
275
296
421
411
164
297
401
92
359
440
Cash
0
285
401
399
9
6
12
49
35
41
Cash Equivalents
275
11
20
12
155
291
389
42
324
399
Short-Term Investments
0
2
8
43
382
287
159
374
136
299
Total Receivables
79
61
95
128
235
186
146
179
215
252
Accounts Receivables
74
58
91
125
229
178
140
169
206
240
Other Receivables
5
4
5
3
6
8
6
10
9
12
Inventory
76
82
107
68
98
110
80
100
84
86
Other Current Assets
57
7
7
9
18
15
14
14
17
19
Total Current Assets
486
450
639
659
897
895
800
759
811
1 097
PP&E Net
116
119
105
94
104
110
104
113
112
112
PP&E Gross
0
0
0
0
104
110
104
113
112
112
Accumulated Depreciation
0
0
0
0
168
185
199
207
220
218
Intangible Assets
0
2
1
1
2
8
5
3
2
4
Goodwill
0
0
0
0
0
0
0
0
0
0
Note Receivable
0
0
0
1
2
1
1
1
1
1
Long-Term Investments
3
14
16
16
19
25
294
436
368
174
Other Long-Term Assets
3
1
2
3
6
1
8
117
124
263
Other Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
609
N/A
586
-4%
764
+30%
775
+1%
1 028
+33%
1 041
+1%
1 212
+16%
1 429
+18%
1 418
-1%
1 651
+16%
Liabilities
Accounts Payable
38
33
60
41
65
52
46
71
61
63
Accrued Liabilities
0
0
0
0
4
16
6
3
3
9
Short-Term Debt
0
0
0
0
73
34
37
58
24
0
Current Portion of Long-Term Debt
66
52
61
0
2
4
4
5
5
0
Other Current Liabilities
135
56
61
89
82
91
87
76
65
92
Total Current Liabilities
240
141
183
131
226
198
180
213
158
164
Long-Term Debt
0
2
2
2
0
14
9
5
0
0
Deferred Income Tax
27
6
5
1
0
0
8
9
7
8
Other Liabilities
8
29
29
28
27
29
30
29
29
30
Total Liabilities
274
N/A
178
-35%
220
+23%
162
-26%
254
+56%
241
-5%
227
-6%
256
+13%
194
-24%
202
+4%
Equity
Common Stock
47
46
46
46
46
46
46
46
44
44
Retained Earnings
288
361
498
567
728
778
943
1 119
1 167
1 377
Other Equity
0
0
0
0
1
24
4
9
13
28
Total Equity
334
N/A
407
+22%
544
+34%
613
+13%
775
+26%
800
+3%
985
+23%
1 174
+19%
1 224
+4%
1 449
+18%
Total Liabilities & Equity
609
N/A
586
-4%
764
+30%
775
+1%
1 028
+33%
1 041
+1%
1 212
+16%
1 429
+18%
1 418
-1%
1 651
+16%
Shares Outstanding
Common Shares Outstanding
5
5
5
5
5
5
5
5
4
4

See Also

Discover More